Zota Healthcare Earnings Call Transcript: Key Takeaways
Zota reported robust revenue growth driven by Dawaa India, though consolidated PAT remains in loss.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Zota reported robust revenue growth driven by Dawaa India, though consolidated PAT remains in loss.
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
Zota Health Care will hold a board meeting on October 28, 2026. The meeting will consider the company's half-yearly unaudited financial results.
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.
Zota Health Care Limited acquired 39,228 equity shares of its subsidiary, Davaindia Health Mart Limited, for Rs. 19.91 Crore. The investment was made via a rights issue subscription.
Zota Health Care Limited acquired 21,00,000 equity shares of its wholly-owned subsidiary, KMHP Ventures Limited, for Rs. 2.10 Crore. This strategic investment supports the rollout of the "Ugo Generic" retail store chain.
Zota Health Care Limited acquired 20,20,000 equity shares in its wholly owned subsidiary, Curexis Ventures Private Limited, for Rs. 4.04 Crore. The transaction was completed via a rights issue subscription.
Zota Health Care Limited announced that shareholders approved all resolutions at its 26th AGM. A final dividend of Re. 1 per share (10%) was declared.
Zota Health Care responded to a proxy advisory firm's negative recommendations on upcoming AGM resolutions, defending proposed director remuneration and related party transactions with its subsidiary.
Zota Health Care Limited announced the cessation of Mrs. Varshabahen Gaurang Mehta as an Independent Director effective September 09, 2026, upon the completion of her tenure.